Is BPAX a good stock to own? Find out who bought BioSante Pharmaceuticals, who sold BioSante Pharmaceuticals (BPAX) stock, and who holds a large position in BioSante Pharmaceuticals.

• Vanguard owns 3.32M shares worth $2.26M
• Tang Capital Management owns 2.83M shares worth $1.92M
• BAM Management owns 2.19M shares worth $5.00M
• STATE STREET CORPORATION owns 1.80M shares worth $1.22M
• UBS AG owns 1.25M shares worth $846904
• Jacobs Levy Equity Management owns 778141 shares worth $529135
• Geode Capital Management owns 755106 shares worth $513472
• Perceptive Advisors owns 650000 shares worth $325000
• TIAA-CREF Investment Management owns 464949 shares worth $316165
• Perella Weinberg Partners Capital Management owns 390000 shares worth $265200
• Barclays owns 348000 shares worth $236640
• GOLDMAN SACHS owns 332238 shares worth $225921
• AQR Capital Management owns 329900 shares worth $164950
• Bank of America Corporation owns 261100 shares worth $130550
• CalPERS owns 206219 shares worth $140228
• Knight Capital owns 199402 shares worth $135593
• Jefferies owns 192000 shares worth $130560
• Charles Schwab Investment Management owns 146800 shares worth $111568
• CITADEL ADVISORS owns 146080 shares worth $99334
• ING Investment Management Co Address: 10 State House Square owns 143900 shares worth $97852
• Nomura Holdings owns 111000 shares worth $75480
• Asset Management Investors owns 107908 shares worth $73377
• ALLIANCEBERNSTEIN owns 103400 shares worth $70312
• Diamondback Capital Management owns 100000 shares worth $50000
• Teachers Advisors owns 97234 shares worth $66119
• WMS Partners owns 89450 shares worth $245987
• Manulife Asset Management owns 88978 shares worth $0

• Kopp Investment Advisors sold on Sept. 30, 2011
• Jennison Associates sold on Sept. 30, 2011
• Manatuck Hill Partners sold on Sept. 30, 2011
• Balyasny Asset Management sold on Sept. 30, 2011
• Gardner Lewis Asset Management sold on Sept. 30, 2011
• ESSEX INVESTMENT MANAGEMENT sold on Sept. 30, 2011
• Eudaimonia Asset Management sold on Sept. 30, 2011
• Driehaus Capital Management sold on Sept. 30, 2011
• Emerald Advisers sold on Sept. 30, 2011
• Deerfield Management Company sold on Sept. 30, 2011
• Partner Fund Management sold on Sept. 30, 2011
• Soros Fund Management sold on Sept. 30, 2011
• Allianz Global Investors of America sold on Sept. 30, 2011
• Partner Investment Management sold on Sept. 30, 2011
• Capstone Investment Advisors sold on Sept. 30, 2011
• Bridgeway Capital Management sold on Sept. 30, 2011
• NOBLE PARTNERS sold on Sept. 30, 2011
• RHUMBLINE ADVISERS sold on Sept. 30, 2011
• Condor Capital Management sold on Sept. 30, 2011
• Emerald Mutual Fund Advisers, Trust sold on Sept. 30, 2011
• Oppenheimer & Co sold on Sept. 30, 2011
• Metropolitan Life Insurance Company sold on Sept. 30, 2011
• Broadfin Capital sold on June 30, 2011
• HIGHBRIDGE CAPITAL MANAGEMENT sold on June 30, 2011
• Highland Capital Management sold on June 30, 2011
• GRT Capital Partners sold on June 30, 2011
• Guggenheim Capital, LLC Managers sold on June 30, 2011
• Dr. Jeffrey R. Jay, M.D sold on March 31, 2011
• Hudson Bay Capital Management sold on March 31, 2011
• D. E. Shaw & Co sold on Dec. 31, 2010
• CQS Cayman Limited Partnership sold on June 30, 2010

• iShares FTSE/Xinhua China 25 Index (FXI)
• iShares MSCI Emerging Markets Indx (EEM)
• NASDAQ OMX (NDAQ)
• Via (VIA.B)
• Orexigen Therapeutics (OREX)
• Hologic (HOLX)
• Molex Incorporated (MOLX)
• Newmont Mining Corporation (NEM)
• Molson Coors Brewing Company (TAP)
• Medtronic (MDT)
• Thoratec Corporation (THOR)
• Cadence Design Systems (CDNS)
• Gilead Sciences (GILD)
• Discovery Communications (DISCK)
• Discovery Communications (DISCA)
• PPL Corporation (PPL)
• Equinix (EQIX)
• Hornbeck Offshore Services (HOS)
• Dendreon Corporation (DNDN)
• BioSante Pharmaceuticals (BPAX)
• iShares MSCI Canada Index (EWC)